These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30446741)

  • 1. Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study.
    Yang J; Jiang J; Cai Y; Li S; Wan L; Zhu J; Liu H; Shao S; Bai H; Wang C; Song X
    Bone Marrow Transplant; 2019 Jul; 54(7):1049-1057. PubMed ID: 30446741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients.
    Ye P; Wu M; Cao J; Pei R; Yuan J; Zhuang H; Fang Y; Lu Y
    Ann Hematol; 2024 Aug; 103(8):3135-3143. PubMed ID: 38809457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation.
    Kim DH; Shin DY; Koh Y; Kim I; Yoon SS; Byun JM; Hong J
    Sci Rep; 2024 Jun; 14(1):13885. PubMed ID: 38880835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies.
    Du Y; Zhang Y; Xu X; Cai Y; Wei Y; Huang C; Yang J; Qiu H; Niu J; Zhou K; Xia X; Shen C; Tong Y; Dong B; Wan L; Song X
    Ann Hematol; 2024 Sep; 103(9):3765-3774. PubMed ID: 38981923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis.
    Luo C; Huang X; Wu G; Huang Y; Ding Y; Huang Z; Song Q; Chen J; Li X; Xu S
    Transplant Cell Ther; 2024 Jul; ():. PubMed ID: 39084262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Haploidentical donor peripheral blood stem cell transplantation using third-party cord blood compared with matched unrelated donor transplantation for patients with hematologic malignancies].
    Ma X; Chen Y; Liu Y; Cheng TT; Chen X; Zeng C; Hua J; Wang SY; Xu YJ
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):141-147. PubMed ID: 38604790
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia.
    Nagler A; Kanate AS; Labopin M; Ciceri F; Angelucci E; Koc Y; Gülbas Z; Arcese W; Tischer J; Pioltelli P; Ozdogu H; Afanasyev B; Wu D; Arat M; Peric Z; Giebel S; Savani B; Mohty M
    Haematologica; 2021 Jun; 106(6):1591-1598. PubMed ID: 32354866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning.
    Wang L; Xu G; Wang L; Jiang J; Gao W; Wan M; Blaise D; Hu J
    Bone Marrow Transplant; 2024 Jul; 59(7):1006-1011. PubMed ID: 38600162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.
    McCurdy SR; Kanakry CG; Tsai HL; Kasamon YL; Showel MM; Bolaños-Meade J; Huff CA; Borrello I; Matsui WH; Brodsky RA; Ambinder RF; Bettinotti MP; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):343-352. PubMed ID: 29055682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation.
    Lee MW; Yeon SH; Seo WH; Ryu H; Lee HJ; Yun HJ; Jo DY; Song IC
    Medicine (Baltimore); 2020 Aug; 99(34):e21571. PubMed ID: 32846764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
    Penack O; Abouqateb M; Peczynski C; Boreland W; Kröger N; Stelljes M; Gedde-Dahl T; Blau IW; Schroeder T; Salmenniemi U; Kulagin A; Peffault de Latour R; Mielke S; Zeiser R; Moiseev I; Schoemans H; Koenecke C; Peric Z
    Leukemia; 2024 May; 38(5):1156-1163. PubMed ID: 38538862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA.
    Zu Y; Zhou J; Fu Y; Fang B; Liu X; Zhang Y; Yu F; Zuo W; Zhou H; Gui R; Li Z; Liu Y; Zhao H; Zhang C; Song Y
    Sci Rep; 2021 Jan; 11(1):253. PubMed ID: 33420287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
    Bazarbachi AH; Labopin M; Raiola AM; Blaise D; Arcese W; Santarone S; Koc Y; Bramanti S; Kulagin A; Kwon M; Sica S; Sanz J; Brissot E; Nagler A; Ciceri F; Mohty M
    Cancer; 2024 Sep; 130(18):3123-3136. PubMed ID: 38758817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Tapering of Cyclosporine Is Feasible in Haploidentical Stem Cell Transplantation: A Single Center Experience.
    Yaman S; Başci S; Bozan E; Seçilmiş S; Candir BA; Yiğenoğlu TN; Çakar MK; Dal MS; Altuntaş F
    Clin Transplant; 2024 Jun; 38(6):e15376. PubMed ID: 39031699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of unrelated cord blood transplantation and HLA-identical sibling peripheral blood stem cell transplantation for the treatment of adult hematological malignancies].
    Zheng CC; Zhu XY; Tang BL; Tong J; Zhang XH; Zhang L; Song KD; Geng LQ; Liu HL; Sun ZM
    Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):673-679. PubMed ID: 28954345
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies.
    Alfaro Moya T; Salas MQ; Santos Carreira A; Atenafu EG; Law AD; Lam W; Pasic I; Kim DDH; Michelis FV; Novitzky Basso I; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Viswabandya A
    Bone Marrow Transplant; 2024 Apr; 59(4):534-540. PubMed ID: 38317015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.
    El Fakih R; Nassani M; Rasheed W; Hanbali A; Almohareb F; Chaudhri N; Alsharif F; Alfraih F; Shaheen M; Alhayli S; Alkhaldi H; Alshaibani A; Alotaibi AS; Alahmari A; Alamer A; Tarig A; Youniss R; Albabtain AA; Alfayez M; Saad A; Ahmed SO; Alzahrani H; Aljurf M
    Transplant Cell Ther; 2024 Mar; 30(3):312.e1-312.e7. PubMed ID: 38185379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation.
    Tian Z; Man Q; Yang Y; Guan H; Wang Y; Luo R; Wang J
    Ann Hematol; 2024 May; 103(5):1729-1736. PubMed ID: 38538977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte Globulin.
    Kanda J; Ando T; Kimura SI; Fujiwara SI; Imada K; Fujisawa S; Tachibana T; Atsuta Y; Kanda Y
    Cell Transplant; 2020; 29():963689720976567. PubMed ID: 33267617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of ATG dose in haploid hematopoietic stem cell transplantation for hematologic malignancies].
    Zhou X; Lu X; Tang L; Yan H; Chen WL; Shi W; Zhong ZD; You Y; Xia LH; Hu Y; Wang HF
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):557-563. PubMed ID: 32810962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.